Bulletin
Investor Alert

London Markets Close in:

Quidel Corp.

NAS: QDEL

GO
/marketstate/country/us

Market open

 --Real time quotes

Apr 14, 2021, 10:52 a.m.

/zigman2/quotes/209081561/composite

$

129.41

Change

-0.19 -0.15%

Volume

Volume 87,358

Real time quotes

/zigman2/quotes/209081561/composite

Previous close

$ 129.60

$ 129.41

Change

-0.19 -0.15%

Day low

Day high

$128.32

$130.49

Open

52 week low

52 week high

$96.05

$306.72

Open

Insider Actions for Quidel Corp.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/30/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
216   Derivative/Non-derivative trans. at $126.39 per share. 27,300
03/30/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
434   Derivative/Non-derivative trans. at $0 per share. 0
03/17/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
2,799   Disposition at $136.05 per share. 380,803
03/17/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
4,601   Disposition at $136.07 per share. 626,058
03/17/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
3,910   Derivative/Non-derivative trans. at $15.4 per share. 60,214
03/17/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
691   Derivative/Non-derivative trans. at $23.41 per share. 16,176
02/24/2021 Werner Kroll
SVP, R&D
5,283   Disposition at $173.71 per share. 917,709
02/23/2021 Werner Kroll
SVP, R&D
173   Disposition at $164.59 per share. 28,474
02/23/2021 Werner Kroll
SVP, R&D
4,662   Disposition at $166.36 per share. 775,570
02/22/2021 Douglas C. Bryant
President & CEO; Director
5,000   Acquisition at $165.3 per share. 826,500
02/22/2021 Werner Kroll
SVP, R&D
3,926   Derivative/Non-derivative trans. at $59.12 per share. 232,105
02/22/2021 Werner Kroll
SVP, R&D
2,970   Derivative/Non-derivative trans. at $47.85 per share. 142,114
02/22/2021 Werner Kroll
SVP, R&D
2,303   Derivative/Non-derivative trans. at $46.41 per share. 106,882
02/22/2021 Werner Kroll
SVP, R&D
3,585   Derivative/Non-derivative trans. at $21.08 per share. 75,571
02/22/2021 Werner Kroll
SVP, R&D
12,784   Disposition at $164.11 per share. 2,097,982
02/18/2021 Douglas C. Bryant
President & CEO; Director
9,282   Derivative/Non-derivative trans. at $210.1 per share. 1,950,148
02/18/2021 Douglas C. Bryant
President & CEO; Director
6,851   Derivative/Non-derivative trans. at $210.1 per share. 1,439,395
02/18/2021 Edward Kieth Russell
SVP, Business Development
1,797   Derivative/Non-derivative trans. at $210.1 per share. 377,549
02/18/2021 Edward Kieth Russell
SVP, Business Development
2,284   Derivative/Non-derivative trans. at $210.1 per share. 479,868
02/18/2021 Robert Joseph Bujarski
Chief Operating Officer
1,797   Derivative/Non-derivative trans. at $210.1 per share. 377,549
02/18/2021 Robert Joseph Bujarski
Chief Operating Officer
2,284   Derivative/Non-derivative trans. at $210.1 per share. 479,868
02/18/2021 Randall J. Steward
Chief Financial Officer
2,396   Derivative/Non-derivative trans. at $210.1 per share. 503,399
02/18/2021 Randall J. Steward
Chief Financial Officer
2,379   Derivative/Non-derivative trans. at $210.1 per share. 499,827
02/18/2021 Tamara A Ranalli
SVP, Molecular Bus. Unit
585   Derivative/Non-derivative trans. at $210.1 per share. 122,908
02/18/2021 Tamara A Ranalli
SVP, Molecular Bus. Unit
421   Derivative/Non-derivative trans. at $210.1 per share. 88,452
02/18/2021 Werner Kroll
SVP, R&D
2,016   Derivative/Non-derivative trans. at $210.1 per share. 423,561
02/18/2021 Werner Kroll
SVP, R&D
2,366   Derivative/Non-derivative trans. at $210.1 per share. 497,096
02/18/2021 Karen C. Gibson
SVP, Digital Health
824   Derivative/Non-derivative trans. at $210.1 per share. 173,122
02/18/2021 Karen C. Gibson
SVP, Digital Health
857   Derivative/Non-derivative trans. at $210.1 per share. 180,055
02/18/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
824   Derivative/Non-derivative trans. at $210.1 per share. 173,122
02/18/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
633   Derivative/Non-derivative trans. at $210.1 per share. 132,993
02/18/2021 Douglas C. Bryant
President & CEO; Director
18,720   Award at $0 per share. 0
02/18/2021 Douglas C. Bryant
President & CEO; Director
13,818   Award at $0 per share. 0
02/18/2021 Edward Kieth Russell
SVP, Business Development
3,623   Award at $0 per share. 0
02/18/2021 Edward Kieth Russell
SVP, Business Development
4,606   Award at $0 per share. 0
02/18/2021 Robert Joseph Bujarski
Chief Operating Officer
3,623   Award at $0 per share. 0
02/18/2021 Robert Joseph Bujarski
Chief Operating Officer
4,606   Award at $0 per share. 0
02/18/2021 Randall J. Steward
Chief Financial Officer
4,831   Award at $0 per share. 0
02/18/2021 Randall J. Steward
Chief Financial Officer
4,798   Award at $0 per share. 0
02/18/2021 Tamara A Ranalli
SVP, Molecular Bus. Unit
1,510   Award at $0 per share. 0
02/18/2021 Tamara A Ranalli
SVP, Molecular Bus. Unit
1,727   Award at $0 per share. 0
02/18/2021 Werner Kroll
SVP, R&D
3,925   Award at $0 per share. 0
02/18/2021 Werner Kroll
SVP, R&D
4,606   Award at $0 per share. 0
02/18/2021 Karen C. Gibson
SVP, Digital Health
1,661   Award at $0 per share. 0
02/18/2021 Karen C. Gibson
SVP, Digital Health
1,727   Award at $0 per share. 0
02/18/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
1,661   Award at $0 per share. 0
02/18/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
1,727   Award at $0 per share. 0
02/17/2021 Douglas C. Bryant
President & CEO; Director
1,393   Derivative/Non-derivative trans. at $217.79 per share. 303,381
02/17/2021 Douglas C. Bryant
President & CEO; Director
4,423   Derivative/Non-derivative trans. at $217.79 per share. 963,285
02/17/2021 Robert Joseph Bujarski
Chief Operating Officer
543   Derivative/Non-derivative trans. at $217.79 per share. 118,259
02/17/2021 Robert Joseph Bujarski
Chief Operating Officer
1,723   Derivative/Non-derivative trans. at $217.79 per share. 375,252
02/17/2021 Werner Kroll
SVP, R&D
542   Derivative/Non-derivative trans. at $217.79 per share. 118,042
02/17/2021 Werner Kroll
SVP, R&D
1,725   Derivative/Non-derivative trans. at $217.79 per share. 375,687
02/17/2021 Douglas C. Bryant
President & CEO; Director
2,808   Award at $0 per share. 0
02/17/2021 Douglas C. Bryant
President & CEO; Director
9,363   Award at $0 per share. 0
02/17/2021 Robert Joseph Bujarski
Chief Operating Officer
1,094   Award at $0 per share. 0
02/17/2021 Robert Joseph Bujarski
Chief Operating Officer
3,646   Award at $0 per share. 0
02/17/2021 Werner Kroll
SVP, R&D
1,055   Award at $0 per share. 0
02/17/2021 Werner Kroll
SVP, R&D
3,519   Award at $0 per share. 0
02/15/2021 Douglas C. Bryant
President & CEO; Director
10,040   Derivative/Non-derivative trans. at $227.97 per share. 2,288,818
02/15/2021 Edward Kieth Russell
SVP, Business Development
3,470   Derivative/Non-derivative trans. at $227.97 per share. 791,055
02/15/2021 Robert Joseph Bujarski
Chief Operating Officer
3,556   Derivative/Non-derivative trans. at $227.97 per share. 810,661
02/15/2021 Randall J. Steward
Chief Financial Officer
3,766   Derivative/Non-derivative trans. at $227.97 per share. 858,535
02/15/2021 Tamara A Ranalli
SVP, Molecular Bus. Unit
165   Derivative/Non-derivative trans. at $227.97 per share. 37,615
02/15/2021 Werner Kroll
SVP, R&D
3,683   Derivative/Non-derivative trans. at $227.97 per share. 839,613
02/15/2021 Karen C. Gibson
SVP, Digital Health
1,883   Derivative/Non-derivative trans. at $227.97 per share. 429,267
02/15/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
234   Derivative/Non-derivative trans. at $227.97 per share. 53,344
02/15/2021 Douglas C. Bryant
President & CEO; Director
20,250   Award at $0 per share. 0
02/15/2021 Edward Kieth Russell
SVP, Business Development
7,172   Award at $0 per share. 0
02/15/2021 Robert Joseph Bujarski
Chief Operating Officer
7,172   Award at $0 per share. 0
02/15/2021 Randall J. Steward
Chief Financial Officer
7,594   Award at $0 per share. 0
02/15/2021 Tamara A Ranalli
SVP, Molecular Bus. Unit
675   Award at $0 per share. 0
02/15/2021 Werner Kroll
SVP, R&D
7,172   Award at $0 per share. 0
02/15/2021 Karen C. Gibson
SVP, Digital Health
3,797   Award at $0 per share. 0
02/15/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
675   Award at $0 per share. 0
02/04/2021 Werner Kroll
SVP, R&D
2,192   Derivative/Non-derivative trans. at $228.68 per share. 501,266
02/04/2021 Werner Kroll
SVP, R&D
4,268   Award at $0 per share. 0
02/03/2021 Douglas C. Bryant
President & CEO; Director
1,882   Derivative/Non-derivative trans. at $236.85 per share. 445,751
02/03/2021 Edward Kieth Russell
SVP, Business Development
575   Derivative/Non-derivative trans. at $236.85 per share. 136,188
02/03/2021 Robert Joseph Bujarski
Chief Operating Officer
791   Derivative/Non-derivative trans. at $236.85 per share. 187,348
02/03/2021 Randall J. Steward
Chief Financial Officer
2,498   Derivative/Non-derivative trans. at $236.85 per share. 591,651
02/03/2021 Tamara A Ranalli
SVP, Molecular Bus. Unit
145   Derivative/Non-derivative trans. at $236.85 per share. 34,343
02/03/2021 Karen C. Gibson
SVP, Digital Health
824   Derivative/Non-derivative trans. at $236.85 per share. 195,164
02/03/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
226   Derivative/Non-derivative trans. at $236.85 per share. 53,528
02/03/2021 Douglas C. Bryant
President & CEO; Director
3,795   Award at $0 per share. 0
02/03/2021 Edward Kieth Russell
SVP, Business Development
1,661   Award at $0 per share. 0
02/03/2021 Robert Joseph Bujarski
Chief Operating Officer
1,661   Award at $0 per share. 0
02/03/2021 Randall J. Steward
Chief Financial Officer
5,616   Award at $0 per share. 0
02/03/2021 Tamara A Ranalli
SVP, Molecular Bus. Unit
593   Award at $0 per share. 0
02/03/2021 Karen C. Gibson
SVP, Digital Health
1,661   Award at $0 per share. 0
02/03/2021 William J. Ferenczy
SVP, Cardio/Metabolic Unit
653   Award at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
49 Purchases
48 Sales
204,798
117,877
Last 6 months
57 Purchases
54 Sales
239,097
137,791
Last 12 months
97 Purchases
73 Sales
439,181
358,802

Officers and Executives

Mr. Douglas C. Bryant
President, Chief Executive Officer & Director
Mr. Robert Joseph Bujarski
Chief Operating Officer
Mr. Randall J. Steward
Chief Financial & Accounting Officer
Dr. Werner Kroll
Senior Vice President-Research & Development
Ms. Karen C. Gibson
SVP-Information Systems & Business Transformation
Mr. Edward Kieth Russell
Senior Vice President-Business Development
Mr. Ratan S. Borkar
Senior VP-International Commercial Operations
Mr. William J. Ferenczy
Senior Vice President-Cardiometabolic Business
Ms. Kathy P. Ordoñez
Director
Ms. Ann D. Rhoads
Director
Mr. Joseph D. Wilkins
Director
Mr. Michael Donald Abney
SVP-North American Sales & Distribution
Mr. Ruben Argueta
Media & Investor Relations Contact
Ms. Michelle A. Hodges
Senior Vice President & General Counsel
Dr. Kenneth F. Buechler
Chairman
Dr. Mary Lake Polan
Independent Director
Dr. Kenneth J. Widder
Independent Director
Mr. Charles P. Slacik
Independent Director
Dr. Matthew William Strobeck
Independent Director
Mr. Edward L. Michael
Independent Director
Link to MarketWatch's Slice.